9,119,848
|
Morphinan derivatives for the treatment of drug overdose |
Oct 13, 10 |
Sep 01, 15 |
ALKERMES PHARMA IRELAND LIMITED, ALKERMES PHARMA IRELAND LIMITED |
9,119,851
|
Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals |
Jun 25, 14 |
Sep 01, 15 |
NEUREN PHARMACEUTICALS LIMITED, NEUREN PHARMACEUTICALS LTD. |
9,119,852
|
Pharmaceutical formulation for treating herpes virus infection comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b) quinoxaline |
Feb 17, 12 |
Sep 01, 15 |
NEUREN PHARMACEUTICALS LIMITED, Not available |
9,119,853
|
Sanglifehrin based compounds |
Feb 09, 11 |
Sep 01, 15 |
NEUROVIVE PHARMACEUTICAL AB, NEUROVIVE PHARMACEUTICAL AB |
9,119,856
|
Method for treating cancer using a dihydropyrimidine derivative |
Mar 23, 15 |
Sep 01, 15 |
KING SAUD UNIVERSITY, KING SAUD UNIVERSITY; KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER; |
9,119,883
|
Reversible pegylated drugs |
Aug 26, 14 |
Sep 01, 15 |
YEDA RESEARCH AND DEVELOPMENT CO. LTD., YEDA RESEARCH AND DEVELOPMENT CO., LTD. |
9,120,711
|
Carboxylation catalysts |
Jun 09, 11 |
Sep 01, 15 |
THE UNIVERSITY OF COURT OF THE UNIVERSITY OF ST ANDREWS, THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS |
9,120,728
|
Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission |
Jan 23, 15 |
Sep 01, 15 |
INTEGRATIVE RESEARCH LABORATORIES SWEDEN AB, INTEGRATIVE RESEARCH LABORATORIES SWEDEN AB |
9,120,745
|
Triazole compounds that modualte HSP90 activity |
May 23, 14 |
Sep 01, 15 |
SYNTA PHARMACEUTICALS CORP., SYNTA PHARMACEUTICALS CORP. |
9,120,746
|
Crystalline form of a 3-phenoxymethylpyrrolidine compound |
Jun 24, 14 |
Sep 01, 15 |
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA R&D IP, LLC |
9,120,747
|
Neprilysin inhibitors |
Oct 10, 13 |
Sep 01, 15 |
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA R&D IP, LLC |
9,120,748
|
Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material |
Oct 31, 07 |
Sep 01, 15 |
IDEMITSU KOSAN CO., LTD., IDEMITSU KOSAN CO. LTD. |
9,120,749
|
Quinoline derivatives and MELK inhibitors containing the same |
Jul 28, 11 |
Sep 01, 15 |
ONCOTHERAPY SCIENCE, INC., ONCOTHERAPY SCIENCE INC. |
9,120,750
|
2-Aminopyridine-based selective neuronal nitric oxide synthase inhibitors |
Mar 06, 14 |
Sep 01, 15 |
NORTHWESTERN UNIVERSITY, NORTHWESTERN UNIVERSITY |
9,120,751
|
Compounds that modulate intracellular calcium |
Aug 16, 13 |
Sep 01, 15 |
CALCIMEDICA, INC., CALCIMEDICA INC. |
9,120,752
|
Pyridine compounds as sodium channel blockers |
Jul 15, 11 |
Sep 01, 15 |
PURDUE PHARMA L.P., PURDUE PHARMA L.P. |
9,120,753
|
Phenol derivatives and pharmaceutical or cosmetic use thereof |
Dec 22, 10 |
Sep 01, 15 |
GALDERMA RESEARCH & DEVELOPMENT, GALDERMA RESEARCH & DEVELOPMENT |
9,120,754
|
Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof |
Jan 30, 12 |
Sep 01, 15 |
DOGWOOD PHARMACEUTICALS, INC., DOGWOOD PHARMACEUTICALS, INC. |
9,120,755
|
Polymorphic forms of ivabradine hydrochloride |
Nov 12, 12 |
Sep 01, 15 |
CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LIMITED |
9,120,756
|
Substituted phenylureas and phenylamides as vanilloid receptor ligands |
Oct 24, 13 |
Sep 01, 15 |
GRUENENTHAL GMBH, GRUENENTHAL GMBH |